John Geoffery Goddard is on the board of Intas Pharmaceuticals Ltd. and Diurnal Group plc and Member of The Association of Corporate Treasurers.

In the past he occupied the position of Finance Director at Zeneca Pharmaceuticals, Head-Strategic Planning & Business Development at AstraZeneca PLC and Chairman for Aptium Oncology, Inc. (a subsidiary of AstraZeneca PLC), Chairman at Dentsply IH, Inc., Chairman of Wellspect HealthCare AB, Chairman of Astra Tech AB and Member of ACT 2013 Ltd.

Mr. Goddard received an undergraduate degree from the University of Kent.